Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

  • There is currently no data for BMK

Acquisition

2 Feb 2015 07:00

RNS Number : 6942D
Benchmark Holdings PLC
02 February 2015
 



 

 

2 February 2015

Benchmark Holdings plc

("Benchmark" or "the Company")

Acquisition of Improve International Limited

Benchmark Holdings Plc announces that it has acquired the entire issued share capital of Improve International Limited ("Improve"), the Swindon-based veterinary continuing professional development ("CPD") provider. Improve will sit within Benchmark's Technical Publishing division, which provides global knowledge transfer, technical insight, e-learning and market analysis for people and businesses working in agriculture, aquaculture and the food supply chain.

Improve organises CPD courses for veterinarians across the UK, Republic of Ireland, Scandinavia and mainland Europe from its bases in the UK and Portugal. The courses are run both privately and in conjunction with universities and other organisations. All of the courses are accredited by either ESVPS (The European School of Veterinary Postgraduate Studies) or Harper Adams University. Currently delivered primarily on a face-to-face basis; Benchmark's directors believe there is considerable scope for online development of the programmes in collaboration with their Technical Publishing division's digital arm.

The consideration for the acquisition comprises an initial payment of £3.2 million in cash and warrants to acquire 259,312 Benchmark ordinary shares at a price of £1.12 per share. The exercise of the warrants is conditional upon the extension of certain business contracts, and the warrants are expected to become exercisable in 2017. If they have not become exercisable and been exercised by 1 December 2017, the warrants will lapse. Additional consideration of up to £3.0 million in cash is payable under an earn-out by reference to achievement in the financial year ending 31 December 2015 of performance targets in excess of anticipated 2014 results.

Improve is being purchased from its three shareholders who comprise the senior management team; David Babington, Heber Alves and Rui Lobao, all of whom will remain with the business.

Improve generated £3.1 million* of revenue and £0.2 million* of earnings before taxation in the year ended 31 December 2013. Net assets at that date were £0.2 million*. Revenue for the year ended 31 December 2014 is expected to be £3.5 million** which represents revenue growth of 13% on 2013. Earnings before taxation for the year ended 31 December 2014 are expected to be £0.5m**.

This significant growth profile has been achieved through expansion across continental Europe - in particular Germany, Spain and Portugal - as well as new market developments in Mexico, USA and Australia and a significant new UK contract.

Improve is forecast to continue to grow both revenue and profit, and the acquisition is expected to be immediately earnings enhancing.

Malcolm Pye, Chief Executive of Benchmark Holdings Plc said:

"The acquisition of Improve will enable us to combine our digital and distance learning expertise with Improve's veterinary content across Europe, enhancing our ability to serve the professionals in our key veterinary markets. This is a significant step forward for our Technical Publishing division in both the food and companion animal markets. We plan to take Improve's successful face-to-face courses and deliver content digitally on an international basis."

* Unaudited aggregated financial statements** Management estimate of unaudited results

 

 

For further information, please contact:

 

 

Benchmark Holdings plc

Tel: 020 7920 3150

Malcolm Pye, CEO

 

Roland Bonney, COO

 

Rachel Aninakwah, Communications

 

 

 

Cenkos Securities PLC

Tel: 020 7397 8900

Ivonne Cantu / Liz Bowman, NOMAD

 

Russell Kerr, Sales

 

 

 

Tavistock Communications

Tel: 020 7920 3150

Matt Ridsdale / Niall Walsh / Keeley Clarke

 

 

Notes to Editors:

Founded in 2000, Benchmark represents a new model in sustainable business development. Over the last decade it has built a profitable group of companies on the economics of a sustainable food supply chain. The company is growing in response to a rapidly increasing demand for sustainable food supply chains, and in particular for seafood, from both mature and emerging markets.

Benchmark is an ethical company with an explicit policy based on the "3E's" definition of a sustainable business - ethics, environment and economics - which guides its strategy and operations.

Following the transformative acquisitions of SalmoBreed and Stofnfiskur in December 2014, the Group now has four divisions: Animal Health which researches, manufactures and markets medicines and vaccines particularly for aquaculture; Sustainability Science which researches and informs sustainable development in the food industry, Technical Publishing which effects technology transfer through online publishing and education, and Animal Breeding and Genetics which is the second largest supplier of salmon eggs and genetic expertise in the world. Benchmark operates internationally with offices in the UK, Ireland, Norway, USA, Brazil, China, Russia, Iceland, and Thailand and, as at 20 January 2015, employs 284 people.

For further information on Benchmark please visit www.bmkholdings.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAKAFELDSEFF
Date   Source Headline
21st Apr 20207:00 amRNSDirector and Divisional Management Changes
7th Apr 20207:00 amRNSAppointment of Chief Executive Officer
2nd Apr 20207:00 amRNSCovid-19 update
31st Mar 202011:12 amRNSTotal Voting Rights
20th Mar 20207:00 amRNSBlock Listing Six Monthly Review
18th Mar 20207:00 amRNSBlock Admission Application
16th Mar 202012:00 pmRNSDirector Dealings
12th Mar 20201:15 pmRNSResult of AGM
9th Mar 20202:01 pmRNSHolding(s) in Company
9th Mar 20201:46 pmRNSDIRECTOR DEALINGS
28th Feb 20207:00 amRNSTotal Voting Rights
28th Feb 20207:00 amRNSQ1 Results
25th Feb 20209:43 amRNSDIRECTOR SHARE OPTIONS
21st Feb 202010:49 amRNSDirector/PDMR Shareholding
20th Feb 20204:10 pmRNSHolding(s) in Company
20th Feb 20209:15 amRNSHolding(s) in Company
17th Feb 20204:28 pmRNSResult of General Meeting and Total Voting Rights
17th Feb 20207:00 amRNSResult of Open Offer
11th Feb 20207:00 amRNSPosting of Annual Report & Accounts &Notice of AGM
31st Jan 20207:00 amRNSTotal Voting Rights
30th Jan 20202:46 pmRNSTimetable for Placing and Open Offer
30th Jan 20207:00 amRNSPlacing and Open Offer
31st Dec 20197:00 amRNSTotal Voting Rights
20th Dec 20199:06 amRNSSecond Price Monitoring Extn
20th Dec 20199:00 amRNSPrice Monitoring Extension
20th Dec 20197:00 amRNSQ4 Results
20th Dec 20197:00 amRNSFull Year Results
4th Dec 20197:00 amRNSDirectorate Change
29th Nov 20197:00 amRNSQ4 and FY Trading Update & Notice of Results
29th Nov 20197:00 amRNSTotal Voting Rights
11th Nov 20197:00 amRNSChief Financial Officer Appointment Update
8th Nov 20197:00 amRNSInvesting in a sustainable future for aquaculture
31st Oct 20197:00 amRNSTotal Voting Rights
28th Oct 20197:00 amRNSUpdate on dissolution of JV with AquaChile
25th Oct 20198:10 amRNSHolding(s) in Company
25th Oct 20197:00 amRNSHolding(s) in Company
11th Oct 201911:15 amRNSDIRECTOR DEALINGS
30th Sep 20197:00 amRNSTotal Voting Rights
27th Sep 20197:00 amRNSDIRECTOR DEALINGS
20th Sep 20197:00 amRNSBlock listing Interim Review
17th Sep 20197:00 amRNSHolding(s) in Company
16th Sep 20197:00 amRNSDIRECTOR DEALINGS
16th Sep 20197:00 amRNSDIRECTOR DEALINGS
12th Sep 20194:25 pmRNSHolding(s) in Company
12th Sep 201911:15 amRNSHolding(s) in Company
11th Sep 20197:00 amRNSUpdate on commercial licensing deals
30th Aug 20197:00 amRNSTotal Voting Rights
19th Aug 20197:00 amRNSDirectorate Change
16th Aug 20193:55 pmRNSDetails of Investor Call
14th Aug 20197:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.